Observational studyNeurology2026
Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials.
Pamela C L Ferreira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it
Observational studyNeurology2026
Pamela C L Ferreira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.